Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ABC Transporter-Mediated Multidrug-Resistant Cancer
Haneen Amawi, Hong‐May Sim, Amit K. Tiwari, et al.
Advances in experimental medicine and biology (2019), pp. 549-580
Closed Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Yuan Li, Zhiyuan Xu, Shanming Ruan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 263
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Silpa Narayanan, Chao‐Yun Cai, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2019) Vol. 48, pp. 100663-100663
Closed Access | Times Cited: 251
Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
Hang Zhang, Hai‐Wei Xu, Charles R. Ashby, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 525-555
Closed Access | Times Cited: 206
Molecular and cellular paradigms of multidrug resistance in cancer
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, et al.
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 157
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 132
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 129
Construction of Fe-doped ZIF-8/DOX nanocomposites for ferroptosis strategy in the treatment of breast cancer
Yuyu Zhong, Zhaoxi Peng, Yanqiong Peng, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 27, pp. 6335-6345
Closed Access | Times Cited: 114
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 113
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yanghong Ni, Xiaoting Zhou, Jia Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 104
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Fatemeh Davodabadi, Seyedeh Fatemeh Sajjadi, Mohammad Sarhadi, et al.
European Journal of Pharmacology (2023) Vol. 958, pp. 176013-176013
Closed Access | Times Cited: 55
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Xin Cao, Jiayun Hou, Quanlin An, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100671-100671
Closed Access | Times Cited: 139
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 135
Perplexing Role of P-Glycoprotein in Tumor Microenvironment
Kianna Robinson, Venkataswarup Tiriveedhi
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 124
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
Louise Marchandet, Morgane Lallier, Céline Charrier, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 683-683
Open Access | Times Cited: 96
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinić, Thomas Efferth, Alfonso T. García‐Sosa, et al.
Drug Resistance Updates (2020) Vol. 52, pp. 100713-100713
Open Access | Times Cited: 80
Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Jun Cao, Mengdi Zhang, Bin Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
Zhaoyu Ma, Heyou Han, Yanli Zhao
Biomaterials (2022) Vol. 293, pp. 121947-121947
Open Access | Times Cited: 49
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Xiangyu Sun, Ping Zhao, Jierou Lin, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 390-415
Open Access | Times Cited: 31
GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells
Zhen Zhu, Hongyu Shen, Jialin Xu, et al.
Drug Resistance Updates (2023) Vol. 69, pp. 100974-100974
Open Access | Times Cited: 23
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
Somayeh Nazari, Fatemeh Mosaffa, Alireza Poustforoosh, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116866-116866
Closed Access | Times Cited: 8
Emerging roles of F-box proteins in cancer drug resistance
Linzhi Yan, Min Lin, Shuya Pan, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100673-100673
Open Access | Times Cited: 66
Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues
Małgorzata Anna Marć, Annamária Kincses, Bálint Rácz, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 453-453
Open Access | Times Cited: 62
Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities
Rabin Neupane, Sai H. S. Boddu, Mariam Sami Abou-Dahech, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 960-960
Open Access | Times Cited: 52
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors
Jason Goebel, Jean Chmielewski, Christine A. Hrycyna
Cancer Drug Resistance (2021)
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top